Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dynavax Technologies Corp (NASDAQ:DVAX)

5.65
Delayed Data
As of Apr 24
 +0.05 / +0.89%
Today’s Change
3.20
Today|||52-Week Range
22.38
+43.04%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close5.60
Today’s open5.65
Day’s range5.51 - 5.73
Volume1,688,911
Average volume (3 months)1,318,556
Market cap$248.4M
Dividend yield--
Data as of 3:59pm ET, 04/24/2017

Growth & Valuation

Earnings growth (last year)+10.15%
Earnings growth (this year)+29.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+172.67%
P/E ratioNM
Price/Sales13.77
Price/Book2.42

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...-0.05-0.74%
OCULOcular Therapeutix I...+0.58+6.59%
MTNBMatinas BioPharma Ho...0.000.00%
ZGNXZogenix Inc-0.10-0.93%
Data as of 3:59pm ET, 04/24/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$11.0M
Annual profit (last year)-$112.4M
Net profit margin-1,018.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts


Search for Jobs